We are proud to present our exceptional results at ESPGHAN 2025 and
excited to share our work on EN311, about preclinical results in Helsinki.

What explores our poster:

 – EN311 A novel formulation for enhanced enzyme delivery in EPI

 – Robust preclinical data that demonstrates a strong therapeutic potential and confirm the promise for clinical success of our candidate EN311
 
Come meet Cloé Fabre and Jessica Tran at Poster #2800, 14-17 Mai 2025
 
 Phase I / II is the next step …